Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 11, 2017 08:00 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Submits 510(k) Application to the FDA for Review of T2Bacteria Panel

LEXINGTON, Mass., Sept. 11, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, today...
September 06, 2017 07:05 ET | Source: T2 Biosystems, Inc.

T2 Biosystems and Cidara Therapeutics Announce Partnership for Commercial Placement of T2Dx Instruments to Support CD101 Drug Trials

LEXINGTON, Mass. and SAN DIEGO, Sept. 06, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient...
September 06, 2017 07:00 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces Collaboration with CDC to Detect Emerging Superbug Candida auris

CDC to Utilize T2Dx Instrument for Testing of Patient Samples and Monitoring Hospital Environments New Application of T2MR Technology for Detection of Candida auris in Patient Skin, Patient Blood and...
August 30, 2017 08:00 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces 11 New Patents Granted in 2017

LEXINGTON, Mass., Aug. 30, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, announced...
August 03, 2017 16:05 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Reports Second Quarter 2017 Financial Results; Provides Company Update

LEXINGTON, Mass., Aug. 03, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, announced...
August 02, 2017 08:00 ET | Source: T2 Biosystems, Inc.

T2 Biosystems to Present at the 37th Annual Canaccord Genuity Growth Conference

LEXINGTON, Mass., Aug. 02, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the development of innovative diagnostic products to improve patient health, today...
July 27, 2017 08:58 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Joins Antimicrobials Working Group as First Diagnostic Member

LEXINGTON, Mass., July 27, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, announced...
July 20, 2017 08:00 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces 2017 Second Quarter Financial and Operational Results Release and Conference Call Date

LEXINGTON, Mass., July 20, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the development of innovative diagnostic products to improve patient health, today...
July 18, 2017 08:00 ET | Source: T2 Biosystems, Inc.

T2 BIOSYSTEMS RECEIVES CE MARK FOR T2BACTERIA™ PANEL ENABLING COMMERCIALIZATION IN EUROPE

LEXINGTON, Mass., July 18, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, announced...
June 19, 2017 08:00 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Chief Scientific Officer Tom Lowery to Present at BIO 2017 Convention

LEXINGTON, Mass., June 19, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, today...